LATANOPROST and DYSPNOEA

Overview

DYSPNOEA is the #7 most commonly reported adverse reaction for LATANOPROST, manufactured by Viatris Specialty LLC. There are 1,600 FDA adverse event reports linking LATANOPROST to DYSPNOEA. This represents approximately 2.0% of all 81,937 adverse event reports for this drug.

Patients taking LATANOPROST who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for LATANOPROST, but still significant enough to appear in the safety profile.

Other Side Effects of LATANOPROST

In addition to dyspnoea, the following adverse reactions have been reported for LATANOPROST:

• TREATMENT FAILURE — 5,915 reports
• DRUG INEFFECTIVE — 3,133 reports
• FATIGUE — 2,228 reports
• EYE IRRITATION — 2,190 reports
• INTRAOCULAR PRESSURE INCREASED — 1,769 reports
• HEADACHE — 1,738 reports
• DEATH — 1,591 reports
• EYE PAIN — 1,591 reports
• DIZZINESS — 1,569 reports
• DIARRHOEA — 1,566 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does LATANOPROST cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 1,600 FDA reports for LATANOPROST. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with LATANOPROST?

DYSPNOEA accounts for approximately 2.0% of all adverse event reports for LATANOPROST, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking LATANOPROST?

If you experience dyspnoea while taking LATANOPROST, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages